Related scientific articles (all)

A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints.

Authors : Fumagalli D, Bedard PL, Nahleh Z, Michiels S, Sotiriou C, Loi S, Sparano JA, Ellis M, Hylton N, Zujewski JA, Hudis C, Esserman L, Piccart-Gebhart M
Year : 2012
Journal : Lancet Oncol
Volume : 13(6)
Pages : e240-8

MicroRNA profile of circulating CD4-positive regulatory T cells in human adults and impact of differentially expressed microRNAs on expression of two genes essential to their function.

Authors : Fayyad-Kazan H, Rouas R, Fayyad-Kazan M, Badran R, El Zein N, Lewalle P, Najar M, Hamade E, Jebbawi F, Merimi M, Romero P, Burny A, Badran B, Martiat P
Year : 2012
Journal : J. Biol. Chem.
Volume : 287(13)
Pages : 9910-22

A joint model for the dependence between clustered times to tumour progression and deaths: A meta-analysis of chemotherapy in head and neck cancer.

Authors : Rondeau V, Pignon JP, Michiels S
Year : 2011
Journal : Stat Methods Med Res
Volume : ?
Pages : ?

High-throughput sequencing reveals novel microRNAs in a retrovirus-induced ovine model of leukemia. (TEXTBOOK Keystone meeting MicroRNAs and non-coding RNAs in cancer, Banff, Canada, February 10-16, 2011)

Authors : Rosewick N, Dehouck C, Cleuter Y, Caiment F, Georges M, Martiat P, Burny A, Van den Broeke A
Year : 2011
Journal : Book
Volume : -
Pages : -

Méthodologie et analyse des essais cliniques, in “Cours de chimiothérapie antitumorale et traitement médical du cancer: 26e cours de l'Institut de cancérologie Gustave-Roussy.” (TEXTBOOK Edited by JC. Soria, S. Vignot, C. Massard, O. Mir. John Libby

Authors : Michiels S
Year : 2011
Journal : Book
Volume : -
Pages : -

Facteurs pronostiques et prédictifs de la réponse un traitement. Invited chapter in “Méthodes biostatistiques appliquées la recherche clinique en cancérologie”. (TEXTBOOK Edited by A. Kramar A. and S. Mathoulin-Pelissier. John Libbey Eurotext)

Authors : Paoletti X, Mathoulin-Pelissier S, Michiels S
Year : 2011
Journal : Book
Volume : -
Pages : -

Multiple testing of treatment-effect-modifying biomarkers in a randomized clinical trial with a survival endpoint.

Authors : Michiels S, Potthoff RF, George SL
Year : 2011
Journal : Stat Med
Volume : 30(13)
Pages : 1502-18

Biomarker studies: a call for a comprehensive biomarker study registry.

Authors : Andre F, McShane LM, Michiels S, Ransohoff DF, Altman DG, Reis-Filho JS, Hayes DF, Pusztai L
Year : 2011
Journal : Nat Rev Clin Oncol
Volume : 8(3)
Pages : 171-6

Multidimensionality of microarrays: statistical challenges and (im)possible solutions.

Authors : Michiels S, Kramar A, Koscielny S
Year : 2011
Journal : Mol. Cell. Neurosci.
Volume : 5 (2)
Pages : 190-6

Leukemia-free survival as a surrogate end point for overall survival in the evaluation of maintenance therapy for patients with acute myeloid leukemia in complete remission.

Authors : Buyse M, Michiels S, Squifflet P, Lucchesi KJ, Hellstrand K, Brune ML, Castaigne S, Rowe JM
Year : 2011
Journal : Haematologica
Volume : 96(8)
Pages : 1106-12

Integrating biomarkers in clinical trials.

Authors : Buyse M, Michiels S, Sargent DJ, Grothey A, Matheson A, de Gramont A
Year : 2011
Journal : Expert Rev. Mol. Diagn.
Volume : 11(2)
Pages : 171-82

Chromatin disruption in the promoter of bovine leukemia virus during transcriptional activation.

Authors : Colin L, Dekoninck A, Reichert M, Calao M, Merimi M, Van den Broeke A, Vierendeel V, Cleuter Y, Burny A, Rohr O, Van Lint C
Year : 2011
Journal : Nucleic Acids Res.
Volume : 39(22)
Pages : 9559-73

Proteomic changes associated with breast cancer progression in the MCF10AT model.

Authors : Fumagalli D, Michiels S, Sotiriou C
Year : 2011
Journal : Pharmacogenomics
Volume : 12(1)
Pages : 9-10

A time series evaluation of the in vivo effect of letrozole on gene expression in breast cancer.

Authors : Fumagalli D, Michiels S, Sotiriou C
Year : 2011
Journal : Pharmacogenomics
Volume : 12(1)
Pages : 10

Gene-expression changes over time in a tamoxifen-treated breast cancer xenograft model.

Authors : Fumagalli D, Michiels S, Sotiriou C
Year : 2011
Journal : Pharmacogenomics
Volume : 12(1)
Pages : 11

CD44+ CD24-/low phenotype and resistance to trastuzumab in HER2-positive breast cancer cell lines.

Authors : Fumagalli D, Michiels S, Sotiriou C
Year : 2011
Journal : Pharmacogenomics
Volume : 12(1)
Pages : 12-3

Differentiation associated regulation of microRNA expression in vivo in human CD8+ T cell subsets.

Authors : Salaun B, Yamamoto T, Badran B, Tsunetsugu-Yokota Y, Roux A, Baitsch L, Rouas R, Fayyad-Kazan H, Baumgaertner P, Devevre E, Ramesh A, Braun M, Speiser D, Autran B, Martiat P, Appay V, Romero P
Year : 2011
Journal : J Transl Med
Volume : 9(null)
Pages : 44

HER2-positive circulating tumor cells in breast cancer.

Authors : Ignatiadis M, Rothé F, Chaboteaux C, Durbecq V, Rouas G, Criscitiello C, Metallo J, Kheddoumi N, Singhal SK, Michiels S, Veys I, Rossari J, Larsimont D, Carly B, Pestrin M, Bessi S, Buxant F, Liebens F, Piccart-Gebhart M, Sotiriou C
Year : 2011
Journal : PLoS One
Volume : 6(1)
Pages : e15624

Low residual proliferation after short-term letrozole therapy is an early predictive marker of response in high proliferative ER-positive breast cancer.

Authors : Bedard PL, Singhal SK, Ignatiadis M, Bradbury I, Haibe-Kains B, Desmedt C, Loi S, Evans DB, Michiels S, Dixon JM, Miller WR, Piccart-Gebhart M, Sotiriou C
Year : 2011
Journal : Endocr Relat Cancer
Volume : 18(6)
Pages : 721-30

Non Hodgkin's lymphomas: a major breakthrough with immunotherapy].

Authors : Firescu R, Muylle K, Roelandts M, de Wind A, Moerman C, Lemort M, Kentos A, Meuleman N, Bron D
Year : 2011
Journal : Rev Med Brux
Volume : 32(2)
Pages : 83-92